Canntab Therapeutics Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Canntab Therapeutics Ltd with three other pharmaceutical manufacturers in North America: Oasmia Pharmaceutical AB of the United States (2019 sales of $218,512.80 of which 65% was Sales of goods), Sangui Biotech International, Incorporated of the United States ($88,001.00 ), and Alterity Therapeutics Ltd which is also based in the United States ($77,573.19 ).

Sales Analysis.